1 The effects of a series of structurally-dissimilar sigma site ligands were examined on high voltage-activated Ca2+ channel activity in two preparations of cultured hippocampal pyramidal neurones. 2 In mouse hippocampal neurones under whole-cell voltage-clamp, voltage-activated Ca2+ channel currents carried by barium ions (I-Ba) were reduced with the rank order (IC50 values in mu M): 1S,2R-(-)-cis-N-methyl-N-[2-(3,4-dichlorophenyl)ethyl]-2- (1-pyrrolidinyl)cyclohexylamine (7.8)>rimcazole (13)> haloperidol (16)>ifenprodil (18)>opipramol (32)>carbetapentane (40)=1-benzylspiro[1,2,3,4-tetrahydronaphthalene-1,4-piperidine] (42)>caramiphen (47)>dextromethorphan (73). At the highest concentrations tested, the compounds almost abolished I-Ba in the absence of any other pharmacological agent. 3 The current-voltage characteristics of the whole-cell I-Ba were unaffected by the test compounds. The drug-induced block was rapid in onset and offset, with the exceptions of carbetapentane and caramiphen where full block was achieved only after two to three voltage-activated currents and was associated with an apparent increase in the rate of inactivation of I-Ba. 4 In rat hippocampal neurones loaded with the Ca2+-sensitive dye Fura-2, rises in intracellular free Ca2+ concentration evoked by transient exposure to 50 mM K+-containing medium, either in the absence or in the presence of 10 mu M nifedipine (to block L-type high voltage-activated Ca2+ channels), were also reversibly attenuated by the sigma ligands. The rank order potencies for the compounds in these experimental paradigms were similar to that observed for blockade of I-Ba in the electrophysiological studies. 5 These results indicate that, at micromolar concentrations, the compounds tested block multiple subtypes of high voltage-activated Ca2+ channels. These actions, which do not appear to be mediated by high-affinity sigma binding sites, may play a role in some of the functional effects previously described for the compounds.